ChronoScale Holdings (CHRN) Opens The Year With Wider Losses, Is The Stock Still A Bargain?
ChronoScale (CHRN) Stock May Be Fairly Priced Despite AI Compute Win
ChronoScale Expands AI Pipeline With $1 Billion Revenue Run Rate In Sight
Wandercraft Acquires Ekso Bionics, Uniting Two Pioneers to Advance and Expand Robotic Mobility
ChronoScale stock jumps on $1B revenue target from AI deals
ChronoScale Signs Contract Extension And New Agreement With AI Infrastructure Customers; Agreements Provide For $1B Annualized Run-rate Revenue By Q3 2027
Nutanix Collaborates With ChronoScale To Jointly Offer Enterprise-Ready AI Infrastructure
ChronoScale (CHRN) Stock Valuation After Sharp 1 Year Surge And Rich P/S Multiple
ChronoScale Plans To Divest Its Esko Bionics Subsidiary; Plans Divestment Completion In Q1
ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy
CHRN Stock Just Started Trading as Applied Digital Spins Off ChronoScale. How to Play Shares Here.
ChronoScale Appoints Cenly Chen CEO
Ekso Bionics Prices $5.852M Private Placement To Purchase 355,960 Shares
Applied Digital (APLD) Rips 17% Higher Ahead of Q2 Earnings
Applied Digital (APLD) Soars 14.6% on AI Surge
Ekso Bionics downgraded to Neutral from Buy at H.C. Wainwright
Applied Digital Is Spinning Out Its Cloud Business. How Should You Play APLD Stock Here?
Ekso Bionics Holdings shares are trading lower after HC Wainwright & Co. downgraded its rating on the stock from Buy to Neutral.
HC Wainwright & Co. Downgrades Ekso Bionics Holdings to Neutral
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.